| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.27 | 7e-07 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0007 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |